Regulation of endometrial adenocarcinoma cell proliferation by Activin-A and its modulation by 17β-estradiol

Molecular and Cellular Endocrinology

Volumn 192, Issue 1-2, 2002, Pages 187-195

  Di Simone, Nicoletta ^a   Schneyer, Alan L ^b   Caliandro, Dario ^a   Castellani, Roberta ^a   Caruso, Alessandro ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Activin; Cancer; Endometrium

Indexed keywords

ACTIVIN A; ACTIVIN RECEPTOR; ANTIMITOTIC AGENT; ESTRADIOL; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; RECEPTOR SUBTYPE; ACTIVIN; ACTIVIN RECEPTOR 1; ACTIVIN RECEPTOR 2; ACTIVIN RECEPTOR TYPE II A; ACTIVIN RECEPTOR TYPE II-A; ACVR1 PROTEIN, HUMAN; BAX PROTEIN, HUMAN; INHIBIN; ONCOPROTEIN; PROTEIN; PROTEIN SUBUNIT; RNA; TUMOR PROTEIN;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENDOMETRIUM CARCINOMA; ESTROGEN ACTIVITY; FEMALE; HUMAN; HUMAN CELL; MITOGENICITY; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ADENOCARCINOMA; APOPTOSIS; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; COMPARATIVE STUDY; DOWN REGULATION; ENDOMETRIUM TUMOR; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; PHYSIOLOGY; SECRETION;

ACTIVIN RECEPTORS, TYPE I; ACTIVIN RECEPTORS, TYPE II; ACTIVINS; ADENOCARCINOMA; APOPTOSIS; CELL DIFFERENTIATION; CELL DIVISION; COMPARATIVE STUDY; DOWN-REGULATION; ENDOMETRIAL NEOPLASMS; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN; INHIBIN-BETA SUBUNITS; NEOPLASM PROTEINS; PROTEIN SUBUNITS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED; BCL-2-ASSOCIATED X PROTEIN; HUMANS; PROTEINS;

EID: 0037188827     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(01)00648-7     Document Type: Article

References (38)

1. Effects of transforming growth factors and regulation of their mRNA levels in two human endometrial adenocarcinoma cell lines
2. An improved method of purifying inhibin radioligand for radioimmunoassay
3. Inhibition of somatotroph growth and growth hormone biosynthesis by activin in vitro
4. Activin-A inhibits proopimelanocortin messenger RNA accumulation and adrenocorticotropin secretion of AtT20 cells
5. Activin inhibition of prostate cancer cell growth: Selective actions on androgen-responsive LNCaP cells
6. Inhibin subunits, follistatin and activin receptors in the human teratocarcinoma cell line tera-2
7. 2-glycoprotein I antibodies
8. Characterization of inhibin/activin subunit, follistatin and activin type II receptors in human ovarian cancer cell lines: A potential role in autocrine growth regulation
9. Activin regulates βa-subunit and activin receptor messenger ribonucleic acid and cellular proliferation in activin-responsive testicular tumor cells
10. Cell-specific expression of activin and its two binding proteins in the rat decidua: Role of alpha 2-macroglobulin and follistatin
11. Study of the control mechanism of growth of endometrial carcinoma cells
12. Effects of estradiol on proliferation of endometrial adenocarcinoma cell line (Ishikawa line)
13. Altered estrogen receptor system in estrogen-unresponsive human endometrial adenocarcinoma cells
14. Establishment of a new human endometrial carcinoma cell line derived from ascites
15. Programmed cell death during regression of the MCF-7 human breast cancer cell following estrogen ablation
16. Bcl-2, bax, and bcl-2 expression in normal and neoplastic ovarian tissue
17. Activin receptors and cellular signaling by the receptor serine kinase family
18. α-Inhibin is a tumor-suppressor gene with gonadal specificity in mice
19. Development of cancer cachexia-like syndrome and adrenal tumors in inhibin deficient mice
20. Growth inhibitory response to Activin A and B by human prostate tumor cell lines, LNCaP and DU145
21. Follistatin, an activin-binding protein, associates with heparan sulfate chains of proteoglycans on follicular granulosa cells
22. Activin-binding protein from rat ovary is follistatin
23. Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors
24. A rapid and convenient assay for counting cells cultured in microwell plates: Application for assessment of growth factors
25. Endometrial carcinoma
26. Immunoreactive inhibin α-subunit in human serum: Implications for radioimmunoassay
27. Characterization of unique binding kinetics of follistatin and activin or inhibin in serum
28. Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-α and p53-deficient mice: The role of activin as an autocrine growth factor
29. ACVR1B (ALK4, activin receptor type 1B) gene mutations in pancreatic carcinoma
30. Molecular heterogeneity of follistatin, an activin-binding protein: Higher affinity of the carboxy-terminal truncated forms for heparin sulfate proteoglycans on the ovarian granulosa cell
31. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells
32. Reproductive and other roles of inhibin and activins
33. A two sites monoclonal antibody immunoradiometric assay for human follistatin: Secretion by a human ovarian teratocarcinoma-derived cell line (PA-1)
34. Activin inhibits basal and androgen-stimulated proliferation and induces apoptosis in the human prostatic cancer cell line, LNCaP
35. Presence of activin, inhibin and follistatin in epithelial ovarian carcinoma
36. ICAM-1-mediated adhesion of peripheral blood monocytes to the maternal surface of placental syncytiotrophoblast: Implications for placental villitis
37. Expression and localization of inhibin/activin subunits and activin receptors in MCF-7 cells, a human breast cancer cell line